| Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review T Depuydt, K Poels, D Verellen, B Engels, C Collen, M Buleteanu, ... Radiotherapy and Oncology 112 (3), 343-351, 2014 | 135 | 2014 |
| The long-and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment J Dhont, J Vandemeulebroucke, M Burghelea, K Poels, T Depuydt, ... Radiotherapy and Oncology 126 (2), 339-346, 2018 | 129 | 2018 |
| Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome B Engels, N Platteaux, R Van den Begin, T Gevaert, A Sermeus, G Storme, ... Radiotherapy and Oncology 110 (1), 155-159, 2014 | 80 | 2014 |
| Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer R Van den Begin, B Engels, T Gevaert, M Duchateau, K Tournel, ... Radiotherapy and Oncology 113 (2), 235-239, 2014 | 59 | 2014 |
| The feasibility of prostate-specific membrane antigen positron emission tomography (PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients OC Guler, B Engels, C Onal, H Everaert, R Van den Begin, T Gevaert, ... Clinical and Translational Oncology 20, 484-490, 2018 | 47 | 2018 |
| Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI R Van den Begin, JP Kleijnen, B Engels, M Philippens, B van Asselen, ... Acta Oncologica 57 (6), 723-727, 2018 | 39 | 2018 |
| Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors: the CHEERS phase 2 randomized clinical trial M Spaas, N Sundahl, V Kruse, S Rottey, D De Maeseneer, F Duprez, ... JAMA oncology 9 (9), 1205-1213, 2023 | 34 | 2023 |
| The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease R Van den Begin, B Engels, C Collen, T de Vin, A Defauw, E Dubaere, ... Radiotherapy and Oncology 133, 113-119, 2019 | 32 | 2019 |
| Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc M Burghelea, D Verellen, K Poels, C Hung, M Nakamura, J Dhont, ... Radiation oncology 11, 1-10, 2016 | 29 | 2016 |
| Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab S Du Four, Y Janssen, A Michotte, AM Van Binst, R Van den Begin, ... Cancer Medicine 7 (10), 4870-4879, 2018 | 26 | 2018 |
| Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system J Dhont, K Poels, D Verellen, K Tournel, T Gevaert, F Steenbeke, ... World Congress on Medical Physics and Biomedical Engineering, June 7-12 …, 2015 | 26 | 2015 |
| Motion management during SBRT for oligometastatic cancer: results of a prospective phase II trial R Van den Begin, B Engels, M Boussaer, J Dhont, M Burghelea, ... Radiotherapy and Oncology 119 (3), 519-524, 2016 | 23 | 2016 |
| Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma T Seremet, S Planken, JK Schwarze, Y Jansen, L Vandeweerd, ... Melanoma Research 29 (1), 85-88, 2019 | 19 | 2019 |
| MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy JPJE Kleijnen, B van Asselen, R Van den Begin, M Intven, JPM Burbach, ... Acta Oncologica 58 (2), 232-236, 2019 | 16 | 2019 |
| Treating patients with dynamic wave arc: first clinical experience M Burghelea, D Verellen, J Dhont, C Hung, T Gevaert, R Van den Begin, ... Radiotherapy and Oncology 122 (3), 347-351, 2017 | 16 | 2017 |
| Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled … M Spaas, N Sundahl, E Hulstaert, V Kruse, S Rottey, D De Maeseneer, ... BMC cancer 21 (1), 514, 2021 | 13 | 2021 |
| The road to dissemination: the concept of Oligometastases and the barriers for widespread disease H AlGhamdi, J Dhont, M Krayem, P De Bruyn, B Engels, D Van Gestel, ... Cancers 14 (8), 2046, 2022 | 9 | 2022 |
| Split-VMAT technique to control the deep inspiration breath hold time for breast cancer radiotherapy S Poeta, Y Jourani, A De Caluwé, R Van den Begin, D Van Gestel, ... Radiation Oncology 16, 1-8, 2021 | 8 | 2021 |
| Dynamic lung tumor tracking for stereotactic ablative body radiation therapy CA Kunos, JM Fabien, JP Shanahan, C Collen, T Gevaert, K Poels, ... Journal of Visualized Experiments: JoVE, 52875, 2015 | 5 | 2015 |
| Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study M Baré, S Poeta, P Fernandes, Y Jourani, FX Otte, S Van Brussel, ... Physics and Imaging in Radiation Oncology 23, 127-133, 2022 | 3 | 2022 |
Dirk VerellenZAS, Iridium Netwerk, Antwerp University - Faculty of Medicine and Health SciencesE-mail confirmado em zas.be